SCHEMBL18501159

SCHEMBL18501159

C=CCOC(=O)[C@H](CSCCCO)NC(=O)OC(C)(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.64
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HTT P42858 1/20 0.50
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
PPARG P37231 5/20 0.38
PPARA Q07869 5/20 0.38
PPARD Q03181 2/20 0.37
CASP1 P29466 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15722117 0.93 SMN1; SMN2 (0.66) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL18501157 0.87 SMN1; SMN2 (0.60) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL18501155 0.86 SMN1; SMN2 (0.59) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL15966639 0.85 SMN1; SMN2 (0.69) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL15966638 0.85 SMN1; SMN2 (0.69) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL15722107 0.85 SMN1; SMN2 (0.62) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL15722121 0.85 SMN1; SMN2 (0.67) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL15722122 0.84 SMN1; SMN2 (0.65) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL15703388 0.83 SMN1; SMN2 (0.66) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT
SCHEMBL7695305 0.83 SMN1; SMN2 (0.53) SMN1; SMN2CYP1A2CYP2C9CYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9567336-B2 Conjugated TLR7 and/or TLR8 and TLR2 agonists INVIVOGEN (FR) 2017-02-14 US disclosed